Apontis Pharma AG
XETRA:APPH

Watchlist Manager

Apontis Pharma AG

XETRA:APPH

Watchlist

Dividends

Discount Rate

Price: 9.64 EUR -1.43% Market Closed

Market Cap: 80.3m EUR

Have any thoughts about
Apontis Pharma AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 9.64 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

APPH Alert

Apontis Pharma AG

9.64

-0.14 (-1.43%)

52 Week Range	3.62 9.9
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Apontis Pharma AG

What unique competitive advantages
does Apontis Pharma AG hold over its rivals?

What risks and challenges
does Apontis Pharma AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Apontis Pharma AG.

What unique competitive advantages
does Apontis Pharma AG hold over its rivals?

What risks and challenges
does Apontis Pharma AG face in the near future?

Has there been any significant insider trading activity
in Apontis Pharma AG recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Apontis Pharma AG.

Provide P/S
for Apontis Pharma AG.

Provide P/E
for Apontis Pharma AG.

Provide P/OCF
for Apontis Pharma AG.

Provide P/FCFE
for Apontis Pharma AG.

Provide P/B
for Apontis Pharma AG.

Provide EV/S
for Apontis Pharma AG.

Provide EV/GP
for Apontis Pharma AG.

Provide EV/EBITDA
for Apontis Pharma AG.

Provide EV/EBIT
for Apontis Pharma AG.

Provide EV/OCF
for Apontis Pharma AG.

Provide EV/FCFF
for Apontis Pharma AG.

Provide EV/IC
for Apontis Pharma AG.

Show me price targets
for Apontis Pharma AG made by professional analysts.

What are the Revenue projections
for Apontis Pharma AG?

How accurate were the past Revenue estimates
for Apontis Pharma AG?

What are the Net Income projections
for Apontis Pharma AG?

How accurate were the past Net Income estimates
for Apontis Pharma AG?

What are the EPS projections
for Apontis Pharma AG?

How accurate were the past EPS estimates
for Apontis Pharma AG?

What are the EBIT projections
for Apontis Pharma AG?

How accurate were the past EBIT estimates
for Apontis Pharma AG?

Compare the revenue forecasts
for Apontis Pharma AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Apontis Pharma AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Apontis Pharma AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Apontis Pharma AG compared to its peers.

Compare the P/E ratios
of Apontis Pharma AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Apontis Pharma AG with its peers.

Analyze the financial leverage
of Apontis Pharma AG compared to its main competitors.

Show all profitability ratios
for Apontis Pharma AG.

Provide ROE
for Apontis Pharma AG.

Provide ROA
for Apontis Pharma AG.

Provide ROIC
for Apontis Pharma AG.

Provide ROCE
for Apontis Pharma AG.

Provide Gross Margin
for Apontis Pharma AG.

Provide Operating Margin
for Apontis Pharma AG.

Provide Net Margin
for Apontis Pharma AG.

Provide FCF Margin
for Apontis Pharma AG.

Show all solvency ratios
for Apontis Pharma AG.

Provide D/E Ratio
for Apontis Pharma AG.

Provide D/A Ratio
for Apontis Pharma AG.

Provide Interest Coverage Ratio
for Apontis Pharma AG.

Provide Altman Z-Score Ratio
for Apontis Pharma AG.

Provide Quick Ratio
for Apontis Pharma AG.

Provide Current Ratio
for Apontis Pharma AG.

Provide Cash Ratio
for Apontis Pharma AG.

What is the historical Revenue growth
over the last 5 years for Apontis Pharma AG?

What is the historical Net Income growth
over the last 5 years for Apontis Pharma AG?

What is the current Free Cash Flow
of Apontis Pharma AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Apontis Pharma AG.

APPH

Cash Flow Statement

Cash from Operating Activities

Apontis Pharma AG
Cash from Operating Activities

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Apontis Pharma AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company		Cash from Operating Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
A	Apontis Pharma AG XETRA:APPH	Cash from Operating Activities -€12.6m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	ATAI Life Sciences NV NASDAQ:ATAI	Cash from Operating Activities -$84.1m	CAGR 3-Years -59%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Bayer AG XETRA:BAYN	Cash from Operating Activities €8B	CAGR 3-Years 41%	CAGR 5-Years 0%	CAGR 10-Years 4%
	Merck KGaA XETRA:MRK	Cash from Operating Activities €4.4B	CAGR 3-Years -3%	CAGR 5-Years 9%	CAGR 10-Years 8%
	Dermapharm Holding SE XETRA:DMP	Cash from Operating Activities €196.8m	CAGR 3-Years -2%	CAGR 5-Years 17%	CAGR 10-Years N/A
	PharmaSGP Holding SE XETRA:PSG	Cash from Operating Activities €26.6m	CAGR 3-Years 20%	CAGR 5-Years 26%	CAGR 10-Years N/A

No Stocks Found

Apontis Pharma AG
Glance View

Market Cap

80.3m EUR

Industry

Pharmaceuticals

APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

Open APPH Analysis

APPH Intrinsic Value

15.03 EUR

Undervaluation 36%

Intrinsic Value

Price

What is Intrinsic Value?

What is Apontis Pharma AG's Cash from Operating Activities?

Cash from Operating Activities
-12.6m EUR

Based on the financial report for Dec 31, 2023, Apontis Pharma AG's Cash from Operating Activities amounts to -12.6m EUR.

Apontis Pharma AG
XETRA:APPH

Apontis Pharma AG
Cash from Operating Activities

Apontis Pharma AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Apontis Pharma AG
Glance View

See Also

What is Apontis Pharma AG's Cash from Operating Activities?

Cash from Operating Activities
-12.6m EUR

Company

Help

Tools

Stocks

Apontis Pharma AG XETRA:APPH

Apontis Pharma AG Cash from Operating Activities

Apontis Pharma AG Cash from Operating Activities Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Apontis Pharma AG Glance View

See Also

What is Apontis Pharma AG's Cash from Operating Activities? Cash from Operating Activities -12.6m EUR

Company

Help

Tools

Stocks

Apontis Pharma AG
XETRA:APPH

Apontis Pharma AG
Cash from Operating Activities

Apontis Pharma AG
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Apontis Pharma AG
Glance View

What is Apontis Pharma AG's Cash from Operating Activities?

Cash from Operating Activities
-12.6m EUR